Answers are grounded in this paper and cite their sources.
Background Sporadic diffuse-type gastric cancer (DGC) lacks a validated precursor sequence analogous to the Correa cascade in intestinal-type gastric cancer, limiting precursor-based surveillance. We aimed to characterise histological abnormalities in the non-neoplastic background mucosa of DGC resection specimens. Methods MEDLINE, Embase and Scopus were searched from inception to November 2025. Eighteen publications contributed 21 non-overlapping analytical cohorts. Random-effects meta-analyses estimated pooled prevalences and odds ratios (ORs) comparing DGC with intestinal-type gastric cancer. Results Pooled prevalences in DGC were 56.8% for Helicobacter pylori (95% CI 39.3–72.8%), 52.9% for chronic gastritis (32.2–72.6%), 30.8% for glandular atrophy (15.3–52.4%) and 37.5% for intestinal metaplasia (24.4–52.7%). Comparative ORs were 0.48 for H. pylori (0.22–1.06), 0.77 for chronic gastritis (0.44–1.34), 0.35 for atrophy (0.17–0.70) and 0.24 for intestinal metaplasia (0.15–0.40). Conclusions Histologically abnormal background mucosa is common in DGC resection specimens, but these cross-sectional findings cannot establish temporality or causality. Prospective studies should distinguish candidate precursor lesions from markers of increased field risk and assess their potential for DGC-specific risk enrichment and earlier detection.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: